[1] |
ZHANG Huabin, LUO Zhongxu, ZHONG Min, HONG Zongyuan, WANG Deguo.
Study on the effect of spinal anesthesia on ventricular arrhythmias in acute myocardial ischemia-reperfusion in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 249-256.
|
[2] |
WANG Qi, ZOU Yunzeng.
New development of lipid-lowering therapy of coronary heart disease: Evinacumab
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 362-364.
|
[3] |
WANG Qi, ZOU Yunzeng.
New development of lipid-lowering therapy of coronary heart disease: Inclisiran
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 365-368.
|
[4] |
WANG Qi, ZOU Yunzeng.
New development of lipid-lowering therapy of coronary heart disease: Bempedoic acid
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 369-372.
|
[5] |
CHANG Shufu .
Progress of medical treatment of coronary heart disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 405-408.
|
[6] |
WANG Ruijie, WANG Liang, XU Dan, ZHOU Miaomiao, LI Jiming.
Effects of PCSK9 inhibitors on blood lipids and inflammatory factors in patients with coronary heart disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 409-417.
|
[7] |
YAN Lei, JIANG Haibin, NAFEISHA Paerhati, REZIWANGULI Yikemu, GENG Boyu, MAIERHABA Maimaitiaili.
Effects of different doses of dexmedetomidine on non-cardiac surgery stress and postoperative sleep in patients with coronary heart disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1340-1346.
|
[8] |
LU Xiya, LI Yuxing, LI Wenzhi, PENG Yuanyuan, HU Yi, WAN Li, CHEN Bilian.
Analysis of prescribing of antiplatelet drug in patients with coronary heart disease in department of geriatrics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1285-1291.
|
[9] |
HU Xiaoyan, XU Qiuping.
Application of levosimendan in severe patients after cardiac surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1027-1032.
|
[10] |
CHEN Miao, ZHANG Xinjin, MENG Hongli, YANG Bei, SONG Lijuan, ZOU Chuannan, GUAN Yingxia.
Therapeutic effect of bisoprolol combined with salvianolate on patients with coronary heart disease after PCI
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 451-457.
|
[11] |
PENG Qiuju, YAN Huacheng, SHI Lei.
Advances in the relationship between cytochrome P450 SNP and susceptibility to coronary heart disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 477-480.
|
[12] |
WANG Weiyu, YU Hao.
Effects of gray drugs in patients with coronary heart disease: A network Meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 301-307.
|
[13] |
WANG Shibiao, WANG Chengyi, WENG Bin, GUO Xiaofeng, LIN Hai.
Comparison of the efficacy of non-invasive USCOM and milrinone in children with severe pneumonia and heart failure and its effect on brain natriuretic peptide levels
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1402-1407.
|
[14] |
SUN Zhizhong, FANG Yixin, HUANG Haijun, WANG Mudan, XU Jiefeng.
Protective effect of Shenfu injection on cardiac muscle and liver and renal function in patients with cardiopulmonary resuscitation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 810-813.
|
[15] |
ZHANG Qiongmin, LI Sisi, ZHANG Jie, ZHU Li.
Curative effect and security of ginkgo-dipyridamolum injection combined hyperbaric oxygen and acupuncture in treatment of patients with sudden deafness
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 668-673.
|